Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Will Lower Aggregate Revenues Hurt Verizon's (VZ) Q4 Earnings?

Published 01/19/2022, 09:30 PM
Updated 07/09/2023, 06:31 AM

Verizon Communications Inc (NYSE:VZ). VZ is scheduled to report fourth-quarter 2021 results on Jan 25, before the opening bell. In the last reported quarter, the telecom giant beat the Zacks Consensus Estimate by 5 cents, delivering a surprise of 3.7%.

The company is expected to have recorded lower aggregate revenues year over year, primarily due to the sale of the Verizon Media unit. However, positive momentum in its core wireless business is likely to have aided the performance.

Factors at Play

During the fourth quarter, Verizon’s subsidiary, Verizon Business, collaborated with CareAR, a Xerox (NASDAQ:XRX) Company, to enhance the latter’s service delivery and customer experience. This has been done by combining Verizon’s 4G and 5G networks and near real-time compute technology with CareAR’s augmented reality and AI-based platform.

Verizon announced the availability of its 5G Home Internet and 5G Business Internet in parts of three cities — Birmingham, AL; Fort Wayne, IN; and Oklahoma City, OK. Customers also have access to 5G Home Internet or 5G Business Internet in parts of Dayton, OH and Jacksonville, FL. Verizon’s investment in 5G Ultra Wideband enables people to experience unmatched speed on their phones and in homes.

Verizon collaborated with Google (NASDAQ:GOOGL) Cloud to bring the power of the cloud closer to connected devices at the edge of Verizon’s network. The combination of Verizon’s private On Site 5G and private 5G Edge with Google Distributed Cloud Edge enable enterprises to unlock the power of 5G and mobile edge computing with greater operational efficiency. These developments are likely to have had a positive impact on Verizon’s performance.

For the December quarter, the Zacks Consensus Estimate for revenues is pegged at $33,767 million, which indicates a decline of 2.7% from the year-ago quarter’s reported figure. The consensus estimate for adjusted earnings per share is pegged at $1.28, which suggests an increase of 5.8%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

What Our Model Says

Our proven model predicts an earnings beat for Verizon this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That’s exactly the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Earnings ESP: Verizon’s Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is +0.23% as the former is pegged at $1.29 and the latter at $1.28.

Zacks Rank: Verizon currently carries a Zacks Rank #3.

Other Stocks to Consider

Here are some other companies that you may want to consider as our model shows that these too have the right combination of elements to post an earnings beat this quarter:

Tesla (NASDAQ:TSLA), Inc. TSLA is slated to release fourth-quarter 2021 results on Jan 26. Tesla has an Earnings ESP of +6.30% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated VRTX is scheduled to release fourth-quarter 2021 results on Jan 26. Vertex Pharmaceuticals has an Earnings ESP of +10.77% and a Zacks Rank #2.

Meritage (NYSE:MTH) Homes Corporation MTH has an Earnings ESP of +3.12% and a Zacks Rank #2. Meritage Homes is set to report fourth-quarter 2021 results on Jan 26.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

As one investor put it, “curing and preventing hundreds of diseases…what should that market be worth?” This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer (NYSE:SAM) Company which shot up +143.0% in little more than 9 months and NVIDIA (NASDAQ:NVDA) which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Verizon Communications Inc. (VZ): Free Stock Analysis Report

Vertex Pharmaceuticals Incorporated (VRTX): Free Stock Analysis Report

Meritage Homes Corporation (MTH): Free Stock Analysis Report

Tesla, Inc. (TSLA): Free Stock Analysis Report

To read this article on Zacks.com click here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.